Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
Abstract The aim of this study was to explore the male predominance in esophageal and gastric adenocarcinoma by evaluating the preventive potential of androgen deprivation therapy (ADT). This matched cohort study was based on a national Swedish database of prostate cancer patients in 2006–2013. Pros...
Guardado en:
Autores principales: | Richard Shore, Jingru Yu, Weimin Ye, Jesper Lagergren, Martin Rutegård, Olof Akre, Pär Stattin, Mats Lindblad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5613e691bb464c97b6d04ced585359f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
por: Rolf Gedeborg, et al.
Publicado: (2021) -
Mortality following hip fracture in men with prostate cancer.
por: Mieke Van Hemelrijck, et al.
Publicado: (2013) -
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
por: Dominick G A Burton, et al.
Publicado: (2013) -
Metabolic changes in patients with prostate cancer with androgen deprivation therapy
por: Maxim N. Peshkov, et al.
Publicado: (2020) -
Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real‐world evidence study
por: Jui‐Ming Liu, et al.
Publicado: (2021)